Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-26-048722
Filing Date
2026-04-24
Accepted
2026-04-24 17:19:52
Documents
2
Period of Report
2026-04-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2612729-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2612729-1_3seq1.xml 3 2736
2 EXHIBIT 24.1 tm2612729d1_ex24-1.htm EX-24.1 6007
  Complete submission text file 0001104659-26-048722.txt   10362
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM Denmark
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM Denmark 4552656554
Evaxion A/S (Issuer) CIK: 0001828253 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address DR. NEERGAARDS VEJ 5F HORSHOLM Denmark DK-2970
Business Address
Bitsch-Norhave Jens (Reporting) CIK: 0002131170 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39950 | Film No.: 26895764